|
|
 |
ALPHA-TOCOPHEROL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKEEGA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKYNZEO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADASUVE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALECENSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
APLENZIN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|